Paediatric Rehabilitation Ingredients Measure: a new tool for identifying paediatric neurorehabilitation content

Rob Forsyth1,2, David Young3, Gemma Kelly4

  • 1Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.

Insights

The Paediatric Rehabilitation Ingredients Measure (PRISM) quantifies interdisciplinary neurorehabilitation content. This tool aids research into treatment effects on outcomes for children with acquired brain injury (ABI).

Area of Science:

  • Neuroscience
  • Rehabilitation Medicine
  • Pediatrics

Background:

  • Quantifying rehabilitation 'dose' and 'content' is crucial for understanding its contribution to outcomes in acquired brain injury (ABI).
  • Previous methods may have overemphasized individual therapy sessions, necessitating a more holistic approach to assessing rehabilitation interventions.
  • The International Classification of Functioning, Disability and Health (ICF) provides a framework for understanding disability and functioning in rehabilitation.

Purpose of the Study:

  • To develop the Paediatric Rehabilitation Ingredients Measure (PRISM) for quantitative estimation of interdisciplinary neurorehabilitation content.
  • To enable studies examining the relationship between delivered rehabilitation treatment and severity-adjusted outcomes in pediatric acquired brain injury (ABI).

Main Methods:

  • Developed using an ingredients-mediators-outcomes model, literature review, and rehabilitation treatment taxonomy initiatives.
  • Item co-development occurred in workshops with rehabilitation professionals.
  • Interrater reliability was assessed in inpatient and residential pediatric rehabilitation settings.

Main Results:

  • PRISM demonstrated excellent acceptability among professionals, despite an initially unfamiliar perspective.
  • Internal consistency improved with practice; interrater reliability (Kendall's W) was good.
  • Modifications enhanced the tool's internal consistency and its value in facilitating interdisciplinary communication.

Conclusions:

  • PRISM effectively identifies the 'active ingredients' of interdisciplinary rehabilitation packages.
  • The tool enhances interdisciplinary communication and collaboration.
  • PRISM holds significant potential as a research instrument for pediatric ABI studies linking rehabilitation to outcomes.
Abstract

Related Concept Videos

Restorative Care01:19

Restorative Care

Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
2.4K
Specialized Care Centers and Settings-II01:30

Specialized Care Centers and Settings-II

Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
1.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
256
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
337